The results of a phase 2 randomized clinical trial show the application of the topical antibiotic mupirocin to multiple body sites was safe and efficacious in eradicating Staphylococcus aureus from
infants in the neonatal intensive care unit (NICU). The findings were published in Pediatrics.
Read more at CIDRAP
Read more at AAP News and Journals